These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10963085)

  • 1. Uveitis, an under-recognized adverse effect of pamidronate. Case report and literature review.
    Rey J; Daumen-Legré V; Pham T; Bernard P; Dahan L; Acquaviva PC; Lafforgue P
    Joint Bone Spine; 2000; 67(4):337-40. PubMed ID: 10963085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminobisphosphonate-associated orbital and ocular inflammatory disease.
    Keren S; Leibovitch I; Ben Cnaan R; Neudorfer M; Fogel O; Greenman Y; Shulman S; Zur D; Habot-Wilner Z
    Acta Ophthalmol; 2019 Aug; 97(5):e792-e799. PubMed ID: 30816018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral uveitis secondary to bisphosphonate therapy.
    Tan YL; Sims J; Chee SP
    Ophthalmologica; 2009; 223(3):215-6. PubMed ID: 19221448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report.
    Tian Y; Wang R; Liu L; Ma C; Lu Q; Yin F
    BMC Musculoskelet Disord; 2016 Feb; 17():72. PubMed ID: 26867651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost.
    Ramasamy B; Quah S; Sahni JN; Palimar P
    J Ocul Pharmacol Ther; 2007 Oct; 23(5):513-5. PubMed ID: 17900233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveitis associated with pamidronate.
    Ghose K; Waterworth R; Trolove P; Highton J
    Aust N Z J Med; 1994 Jun; 24(3):320. PubMed ID: 7980223
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative effect of topical diclofenac and topical dexamethasone on anterior chamber flare and postoperative pain following rhegmatogenous retinal detachment surgery.
    Ben Yahia S; Kahloun R; Abroug N; Kaibi I; Laadhari G; Jelliti B; Khairallah M
    Int Ophthalmol; 2016 Oct; 36(5):623-8. PubMed ID: 26757935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pamidronate-induced nephrotoxic tubular necrosis--a case report.
    Smetana S; Michlin A; Rosenman E; Biro A; Boaz M; Katzir Z
    Clin Nephrol; 2004 Jan; 61(1):63-7. PubMed ID: 14964460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pamidronate and uveitis.
    De S; Meyer P; Crisp AJ
    Br J Rheumatol; 1995 May; 34(5):479. PubMed ID: 7788181
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pamidronate and uveitis].
    Alegre de Miquel C; Moreno-Ruzafa E; González-Fernández MJ
    Med Clin (Barc); 2005 Nov; 125(17):678. PubMed ID: 16324500
    [No Abstract]   [Full Text] [Related]  

  • 11. Scleritis and other ocular side effects associated with pamidronate disodium.
    Fraunfelder FW; Fraunfelder FT; Jensvold B
    Am J Ophthalmol; 2003 Feb; 135(2):219-22. PubMed ID: 12566027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-associated orbital inflammatory disease and uveitis anterior--a case report and review.
    Böni C; Kordic H; Chaloupka K
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):367-9. PubMed ID: 23629782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
    Arcinue CA; Cerón OM; Foster CS
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paget's disease: ocular complications of disodium pamidronate treatment.
    O'Donnell NP; Rao GP; Aguis-Fernandez A
    Br J Clin Pract; 1995; 49(5):272-3. PubMed ID: 7492469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Topical Corticosteroids and Non-steroidal Anti-inflammatory Drugs in the Therapy of Non-infectious Uveitis].
    Doycheva D; Deuter C; Grajewski R
    Klin Monbl Augenheilkd; 2018 May; 235(5):586-591. PubMed ID: 29739028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior uveitis: an under-recognized adverse effect of pamidronate: 2 case reports.
    Haverbeke G; Pertile G; Claes C; Zeyen T
    Bull Soc Belge Ophtalmol; 2003; (290):71-6. PubMed ID: 14750233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pamidronate disodium and possible ocular adverse drug reactions.
    Macarol V; Fraunfelder FT
    Am J Ophthalmol; 1994 Aug; 118(2):220-4. PubMed ID: 8053468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children.
    Noguera A; Ros JB; Pavía C; Alcover E; Valls C; Villaronga M; González E
    J Pediatr Endocrinol Metab; 2003; 16(4):529-36. PubMed ID: 12793604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sugar absorption test in the evaluation of the gastrointestinal intolerance to bisphosphonates: studies with oral pamidronate.
    Twiss IM; Burggraaf J; Schoemaker RC; van Elburg RM; den Hartigh J; Cohen AF; Vermeij P
    Clin Pharmacol Ther; 2001 Jun; 69(6):431-7. PubMed ID: 11406740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diclofenac drops to treat inflammation after cataract surgery.
    Herbort CP; Jauch A; Othenin-Girard P; Tritten JJ; Fsadni M
    Acta Ophthalmol Scand; 2000 Aug; 78(4):421-4. PubMed ID: 10990044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.